SNOMED CT-concept
|
waarneembare entiteit (waarneembare entiteit)
waarneembare entiteit
Observable entity
Id
363787002
Status
Primitive
Global Patient Set
|
5-hydroxyindoleacetate in cerebrospinal fluid
aankleuring van membrana cellularis
aantal intralobulaire nefrogene resten in preparaat van weefsel verkregen door excisie
aantal jodium-125 zaadjes
aantal onderzochte lymfeklieren verkregen door okselklierdissectie
aantal perilobulaire nefrogene resten in preparaat van weefsel verkregen door excisie
aanwezigheid van nefrogene resten in preparaat van weefsel verkregen door excisie
aanwezigheid van zenuw binnen contour van de tumor
Age AND/OR growth period
17
algemene klinische toestand
42
anatomische locatie mucus
anatomische locatie van zenuw
Antimicrobial susceptibility of organism by matrix assisted laser desorption ionization time of flight mass spectrometry
Arginine in cerebrospinal fluid
Assessment score
667
Benzodiazepine in urine by confirmatory technique
bepaling van antilichamen tegen SARS-CoV-2
bepaling van SARS-CoV-2-antigeen
1
bevinding van anamnese en/of onderzoek
155
Clinical performance measure
3
Concentration of 1,5-anhydroglucitol
Concentration of neurotransmitter in blood
Cycle threshold for nucleic acid detection in specimen using real-time polymerase chain reaction
detectie van SARS-CoV-2
2
Detection and differentiation of antibody to human immunodeficiency virus type 1 and human immunodeficiency virus type 2 by immunoassay
Detection of antibody to infective organism
6
Detection of Legionella pneumophila antigen in urine
Detection of Neisseria gonorrhoeae nucleic acid by amplified probe technique
Detection of opiate by screening method
Detection of Streptococcus pneumoniae antigen in urine
diameter van zenuw
Differential count of white blood cells by automated method
Differential count of white blood cells by manual method
Direct antiglobulin test of cord blood
Disease activity score using 28 joint count
1
Environment observable
11
faciliteiten benodigd bij consult
fase van ziekte
Feature of entity
12
geschiktheid om deel te nemen aan klinische studie
Giardia lamblia antigen by enzyme immunoassay
Glucose in blood one hour after glucose dose in pregnancy
Glucose in blood one hour postprandial
grootte van zenuw
Hematology observable
5
Histologic grade of dysplasia at proximal surgical margin
histologische type van epitheliale cel
histologische type van niet epitheliale cel
Identification code
6
Identification of bacteria by matrix assisted laser desorption ionization time of flight mass spectrometry
Identification of bacteria in sputum by culture
Identification of fungus by matrix assisted laser desorption ionization time of flight mass spectrometry
Identification of organism in smear by Gram stain
1
Identification of organism in wet smear by potassium hydroxide preparation
Identification of ova and parasites in fecal smear by concentration and trichrome stain
Imaging observable
29
Immunoglobulin G antibody to cyclic citrullinated peptide
in aanmerking komende klinische studies
Indocyanine green clearance rate
Interferon gamma in blood by Mycobacterium tuberculosis antigen stimulation
interpretatie van bevindingen
24
kwalitatieve distributie van nefrogene resten in preparaat van weefsel verkregen door excisie
Laboratory biosafety level
Lactate in blood
2
Lactate in cerebrospinal fluid
Length of cross section of myometrium in uterus specimen
Low density lipoprotein cholesterol by direct assay
Major crossmatch compatibility by immediate spin technique
mate van blootstelling aan daglicht
Measurement of aminotransferase
1
Measurement of heme oxygenase-1
Method of Gleason scoring system for grading malignant neoplasm of prostate technique used to grade neoplasm
Molecular, genetic AND/OR cellular observable
4
Monitoring features
4
Movement observable
13
Number of occurrences observable
4
observatie betreffende afwijkend weefsel
25
observatie betreffende behandeling met geneesmiddel
25
observatie betreffende functioneren
118
observatie betreffende lichaamsvloeistof
9
observatie betreffende lymfeklier
30
observatie betreffende sociale en persoonlijke voorgeschiedenis
24
Observation using immunohistochemistry
42
Opiate in urine by confirmatory technique
Parameter
3
Population statistic
4
Prescription observable
6
Presence of atelectasis and/or obstructive pneumonitis extending to hilar structure of resected lung specimen
Presence of Helicobacter pylori in stool
1
Presence of Streptococcus agalactiae in genital system by organism specific culture
Presence of white blood cells in stool
Process
5
Radiation therapy observable
1
ratio lymfocyten positief voor CD4+/CD8+ antigeen met broncho-alveolaire lavage
reden voor afwijken van richtlijnen
Rhesus antibody observable
Rheumatoid factor in serum
Risk level
7
Rubella virus antibody by screening latex agglutination
Saccharopine in cerebrospinal fluid
Smooth muscle actin immunoglobulin G antibody
Specimen observable
60
Status of intactness of mesorectal specimen
1
Status of intactness of renal capsule in excised kidney specimen
status van patiëntcontact in multidisciplinair overleg
Substance observable
9
Temporal observable
80
Thiamine in whole blood
Treponema pallidum antibody by screening enzyme immunoassay
trigger
type consult
type gedrag en/of manier van communiceren bij benaderen van zorgafnemer
urgentie
Viral load
zorgfase
zorgvormtype van onvrijwillige zorg
